ERBB2 and breast carcinoma: For example, Li et al. reported that Anti-HER2 antibody-decorated poly(lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG)/ PLGA nanoparticles can be used to target breast cancer cells.